Table of Content

1 Influenza Vaccines Market Introduction and Overview
1.1 Influenza Vaccines Definition
1.2 Market Size Analysis by Types
1.3 Market Size Analysis by Application
1.4 Research Purposes
1.5 Report Timeline
1.6 Economic Analysis of Global Regions
1.7 Inflation Analysis
1.8 The Impact of the Russian-Ukrainian War on the Market
2 Market Competition by Manufacturers
2.1 Global Influenza Vaccines Revenue and Market Share by Manufacturer
2.2 Manufacturers Influenza Vaccines Production Sites, Area Served, Product Types
2.3 Influenza Vaccines Market Competitive Situation and Trends
2.3.1 Influenza Vaccines Market Concentration Rate
2.3.2 Global Top 5 and Top 10 Players Market Share by Revenue in 2024
2.3.3 Mergers & Acquisitions, Expansion
3 Players Profiles
3.1 AstraZeneca
3.1.1 AstraZeneca Company Profile
3.1.2 Influenza Vaccines Product Overview
3.1.3 AstraZeneca Influenza Vaccines Market Performance (2019-2024)
3.1.4 AstraZeneca Business Overview
3.2 CSL
3.2.1 CSL Company Profile
3.2.2 Influenza Vaccines Product Overview
3.2.3 CSL Influenza Vaccines Market Performance (2019-2024)
3.2.4 CSL Business Overview
3.3 GlaxoSmithKline
3.3.1 GlaxoSmithKline Company Profile
3.3.2 Influenza Vaccines Product Overview
3.3.3 GlaxoSmithKline Influenza Vaccines Market Performance (2019-2024)
3.3.4 GlaxoSmithKline Business Overview
3.4 Sanofi
3.4.1 Sanofi Company Profile
3.4.2 Influenza Vaccines Product Overview
3.4.3 Sanofi Influenza Vaccines Market Performance (2019-2024)
3.4.4 Sanofi Business Overview
3.5 Altimmune
3.5.1 Altimmune Company Profile
3.5.2 Influenza Vaccines Product Overview
3.5.3 Altimmune Influenza Vaccines Market Performance (2019-2024)
3.5.4 Altimmune Business Overview
3.6 BionVax
3.6.1 BionVax Company Profile
3.6.2 Influenza Vaccines Product Overview
3.6.3 BionVax Influenza Vaccines Market Performance (2019-2024)
3.6.4 BionVax Business Overview
3.7 FluGen
3.7.1 FluGen Company Profile
3.7.2 Influenza Vaccines Product Overview
3.7.3 FluGen Influenza Vaccines Market Performance (2019-2024)
3.7.4 FluGen Business Overview
3.8 FOLIA BIOTECH
3.8.1 FOLIA BIOTECH Company Profile
3.8.2 Influenza Vaccines Product Overview
3.8.3 FOLIA BIOTECH Influenza Vaccines Market Performance (2019-2024)
3.8.4 FOLIA BIOTECH Business Overview
3.9 Genentech
3.9.1 Genentech Company Profile
3.9.2 Influenza Vaccines Product Overview
3.9.3 Genentech Influenza Vaccines Market Performance (2019-2024)
3.9.4 Genentech Business Overview
3.10 Green Cross
3.10.1 Green Cross Company Profile
3.10.2 Influenza Vaccines Product Overview
3.10.3 Green Cross Influenza Vaccines Market Performance (2019-2024)
3.10.4 Green Cross Business Overview
3.11 Medicago
3.11.1 Medicago Company Profile
3.11.2 Influenza Vaccines Product Overview
3.11.3 Medicago Influenza Vaccines Market Performance (2019-2024)
3.11.4 Medicago Business Overview
3.12 Moderna Therapeutics
3.12.1 Moderna Therapeutics Company Profile
3.12.2 Influenza Vaccines Product Overview
3.12.3 Moderna Therapeutics Influenza Vaccines Market Performance (2019-2024)
3.12.4 Moderna Therapeutics Business Overview
3.13 Novavax
3.13.1 Novavax Company Profile
3.13.2 Influenza Vaccines Product Overview
3.13.3 Novavax Influenza Vaccines Market Performance (2019-2024)
3.13.4 Novavax Business Overview
4 Global Influenza Vaccines Historical and Forecast Market Analysis by Type
4.1 Global Influenza Vaccines Revenue and Market Share by Type
4.2 Global Influenza Vaccines Revenue Market Forecast by Type (2024-2030)
5 Global Influenza Vaccines Historical and Forecast Market Analysis by Application
5.1 Global Influenza Vaccines Revenue Market Share by Application (2019-2024)
5.2 Influenza Vaccines Revenue Market Forecast by Application (2024-2030)
6 Global Market Growth Trends Analysis
6.1 Global Influenza Vaccines Market Size & Forecast (2019-2030)
6.2 Influenza Vaccines Growth Trends Analysis by Regions
6.2.1 Influenza Vaccines Market Size by Regions: 2019 VS 2024 VS 2030
6.2.2 Influenza Vaccines Historic Revenue Market Size by Regions (2019-2024)
6.2.3 Influenza Vaccines Forecasted Revenue Market Size by Regions (2024-2030)
6.2.4 North America Influenza Vaccines Market Size & Forecast (2019-2030)
6.2.5 Europe Influenza Vaccines Market Size & Forecast (2019-2030)
6.2.6 China Influenza Vaccines Market Size & Forecast (2019-2030)
6.2.7 Japan Influenza Vaccines Market Size & Forecast (2019-2030)
6.2.8 Korea Influenza Vaccines Market Size & Forecast (2019-2030)
6.2.9 Southeast Asia Influenza Vaccines Market Size & Forecast (2019-2030)
6.2.10 India Influenza Vaccines Market Size & Forecast (2019-2030)
6.2.11 South America Influenza Vaccines Market Size & Forecast (2019-2030)
6.2.12 Middle East & Africa Influenza Vaccines Market Size & Forecast (2019-2030)
7 North America
7.1 North America Influenza Vaccines Revenue by Players
7.2 North America Influenza Vaccines Revenue by Types
7.3 North America Influenza Vaccines Revenue by Applications
7.4 North America Influenza Vaccines Revenue, Gross and Gross Margin (2019-2024)
7.5 North America PEST Analysis
8 Europe
8.1 Europe Influenza Vaccines Revenue by Players
8.2 Europe Influenza Vaccines Revenue by Types
8.3 Europe Influenza Vaccines Revenue by Applications
8.4 Europe Influenza Vaccines Revenue, Gross and Gross Margin (2019-2024)
8.5 Europe PEST Analysis
9 China
9.1 China Influenza Vaccines Revenue by Players
9.2 China Influenza Vaccines Revenue by Types
9.3 China Influenza Vaccines Revenue by Applications
9.4 China Influenza Vaccines Revenue, Gross and Gross Margin (2019-2024)
9.5 China PEST Analysis
10 Japan
10.1 Japan Influenza Vaccines Revenue by Players
10.2 Japan Influenza Vaccines Revenue by Types
10.3 Japan Influenza Vaccines Revenue by Applications
10.4 Japan Influenza Vaccines Revenue, Gross and Gross Margin (2019-2024)
10.5 Japan PEST Analysis
11 Korea
11.1 Korea Influenza Vaccines Revenue by Players
11.2 Korea Influenza Vaccines Revenue by Types
11.3 Korea Influenza Vaccines Revenue by Applications
11.4 Korea Influenza Vaccines Revenue, Gross and Gross Margin (2019-2024)
11.5 Korea PEST Analysis
12 Southeast Asia
12.1 Southeast Asia Influenza Vaccines Revenue by Players
12.2 Southeast Asia Influenza Vaccines Revenue by Types
12.3 Southeast Asia Influenza Vaccines Revenue by Applications
12.4 Southeast Asia Influenza Vaccines Revenue, Gross and Gross Margin (2019-2024)
12.5 Southeast Asia PEST Analysis
13 India
13.1 India Influenza Vaccines Revenue by Players
13.2 India Influenza Vaccines Revenue by Types
13.3 India Influenza Vaccines Revenue by Applications
13.4 India Influenza Vaccines Revenue, Gross and Gross Margin (2019-2024)
13.5 India PEST Analysis
14 South America
14.1 South America Influenza Vaccines Revenue by Players
14.2 South America Influenza Vaccines Revenue by Types
14.3 South America Influenza Vaccines Revenue by Applications
14.4 South America Influenza Vaccines Revenue, Gross and Gross Margin (2019-2024)
14.5 South America PEST Analysis
15 Middle East & Africa
15.1 Middle East & Africa Influenza Vaccines Revenue by Players
15.2 Middle East & Africa Influenza Vaccines Revenue by Types
15.3 Middle East & Africa Influenza Vaccines Revenue by Applications
15.4 Middle East & Africa Influenza Vaccines Revenue, Gross and Gross Margin (2019-2024)
15.5 Middle East & Africa PEST Analysis
16 Influenza Vaccines Business Cost Analysis
16.1 Proportion of Business Cost Structure
16.1.1 Labor Cost
16.1.2 Operating Expenses
16.2 Influenza Vaccines Industrial Chain Analysis
17 Influenza Vaccines Industry Dynamic Analysis
17.1 Influenza Vaccines Market Trends Analysis
17.2 Influenza Vaccines Market Drivers Analysis
17.3 Influenza Vaccines Market Challenges Analysis
17.4 Influenza Vaccines Market Restraints Analysis
18 Research Findings and Conclusion